Protective effect of docosahexaenoic acid against brain injury in ischemic rats

Journal of Nutritional Biochemistry

Volumn 20, Issue 9, 2009, Pages 715-725

  Pan, Hung Chuan ^a,b   Kao, Tsung Kuei ^c   Ou, Yen Chuan ^b   Yang, Dar Yu ^d   Yen, Yu Ju ^b   Wang, Chun Chiang ^b   Chuang, Yu Han ^b   Liao, Su Lan ^b   Raung, Shue Ling ^b   Wu, Ching Wen ^b   Chiang, An Na ^e   Chen, Chun Jung ^b,f,g  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

^d CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f TUNGHAI UNIVERSITY   (Taiwan)

^g NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cerebral ischemia reperfusion; DHA; Inflammation; Neuroprotection; Oxidative stress

Indexed keywords

CASPASE 3; DOCOSAHEXAENOIC ACID; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL INFILTRATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLIA CELL; INFLAMMATORY CELL; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TREATMENT DURATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION; CASPASE 3; CEREBROVASCULAR TRAUMA; DOCOSAHEXAENOIC ACIDS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUTATHIONE; HYPOXIA-ISCHEMIA, BRAIN; INTERLEUKIN-6; LIPID PEROXIDATION; MALE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 68249126664     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.06.014     Document Type: Article

References (53)

1. Choi D.W. Excitotoxic cell death. J Neurobiol 23 (1992) 1261-1276
2. Siesjö B.K. Pathophysiology and treatment of focal cerebral ischemia; mechanisms of damage and treatment. J Neurosurg 77 (1992) 337-354
3. Linnik M.D., Zobrist R.H., and Hatfield M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24 (1993) 2002-2008
4. Hamann G.F., Okada Y., and del Zoppo G.J. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab 16 (1996) 1373-1378
5. Chen C.J., Cheng F.C., Liao S.L., Chen W.Y., Lin N.N., and Kuo J.S. Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion. Neurosci Lett 287 (2000) 113-116
6. Vila N., Castillo J., Dávalos A., and Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31 (2000) 2325-2329
7. Liao S.L., Chen W.Y., Raung S.L., Kuo J.S., and Chen C.J. Association of immune responses and ischemic brain infarction in rat. NeuroReport 12 (2001) 1943-1947
8. Cho S., Liu D., Gonzales C., Zaleska M.M., and Wood A. Temporal assessment of caspase activation in experimental models of focal and global ischemia. Brain Res 982 (2003) 146-155
9. Gursoy-Ozdemir Y., Can A., and Dalkara T. Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35 (2004) 1449-1453
10. Mehta S.L., Manhas N., and Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54 (2007) 34-66
11. Kim J.S., Chopp M., and Gautam S.C. High dose methylprednisolone therapy reduces expression of JE/MCP-1 mRNA and macrophage accumulation in the ischemic rat brain. J Neurol Sci 128 (1995) 28-35
12. Clark W.M., and Zivin J.A. Antileukocyte adhesion therapy: preclinical trials and combination therapy. Neurology 49 (1997) S32-S38
13. Satoh S., Kobayashi T., Hitomi A., Ikegaki I., Suzuki Y., Shibuya M., et al. Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction. Jpn J Pharmacol 80 (1999) 41-48
14. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96 (1999) 13496-13500
15. Phillips J.B., Williams A.J., Adams J., Elliott P.J., and Tortella F.C. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke 31 (2000) 1686-1693
16. Nagel S., Genius J., Heiland S., Horstmann S., Gardner H., and Wagner S. Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat. Brain Res 1132 (2007) 210-217
17. Choi-Kwon S., Park K.A., Lee H.J., Park M.S., Lee J.H., Jeon S.E., et al. Temporal changes in cerebral antioxidant enzyme activities after ischemia and reperfusion in a rat focal brain ischemia model: effect of dietary fish oil. Dev Brain Res 152 (2004) 11-18
18. Wei L., Cui L., Snider B.J., Rivkin M., Yu S.S., Lee C.S., et al. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol Dis 19 (2005) 183-193
19. Wong L.F., Ralph G.S., Walmsley L.E., Bienemann A.S., Parham S., Kingsman S.M., et al. Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus. Mol Ther 11 (2005) 89-95
20. Choi J.S., Kim H.Y., Cha J.H., and Lee M.Y. Ischemic preconditioning-induced activation of ERK1/2 in the rat hippocampus. Neurosci Lett 409 (2006) 187-191
21. Ricci S., Celani M.G., Righetti E., Caruso A., Medio G.D., Trovarelli G., et al. Fatty acid dietary intake and the risk of ischemic stroke: a multicentre case-control study. J Neurol 244 (1997) 360-364
22. Iso H., Sato S., Umemura U., Kudo M., Koike K., Kitamura A., et al. Linoleic acid, other fatty acids, and the risk of stroke. Stroke 33 (2002) 2086-2093
23. Tilvis R.S., Erkinjuntti T., Sulkava R., Farkila M., and Miettinen T.A. Serum lipids and fatty acids in ischemic stroke. Am Heart J 113 (1987) 615-619
24. Simon J.A., Fong J., Bernert J.T., and Browner W.S. Serum fatty acids and the risk of stroke. Stroke 26 (1995) 778-782
25. Politsis J.G., Coplin W.M., O'Regan M.H., Wellwood J.M., Diaz F.G., Fairfax M.R., et al. Measurement of free fatty acids in cerebrospinal fluid from patients with hemorrhagic and ischemic stroke. Brain Res 985 (2003) 198-201
26. Cao D., Yang B., Hou L., Xu J., Xue R., Sun L., et al. Chronic daily administration of ethyl docosahexaenoate protects against gerbil brain ischemic damage through reduction of arachidonic acid liberation and accumulation. J Nutr Biochem 18 (2007) 297-304
27. Yang D.Y., Pan H.C., Yen Y.J., Wang C.C., Chuang Y.H., Chen S.Y., et al. Detrimental effects of post-treatment of fatty acids on brain injury in ischemic rats. Neurotoxicology 28 (2007) 1220-1229
28. Katsumata T., Katayama Y., Obo R., Muramatsu H., Ohtori T., and Terashi A. Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. Eur J Pharmacol 372 (1999) 167-174
29. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., and Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 19 (2000) 1784-1793
30. Blondeau N., Widmann C., Lazdunski M., and Heurteaux C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 109 (2002) 231-241
31. de Wilde M.C., Farkas E., Gerrits M., Kiliaan A.J., and Luiten P.G.M. The effect of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion. Brain Res 947 (2002) 166-173
32. Cao D.H., Xu J.F., Xue R.H., Zheng W.F., and Liu Z.L. Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. Pharmacol Biochem Behav 79 (2004) 651-659
33. Cao D., Li M., Xue R., Zheng W., Liu Z., and Wang X. Chronic administration of ethyl docosahexaenoate decreases mortality and cerebral edema in ischemic gerbils. Life Sci 78 (2005) 74-81
34. Cao D., Zhou C., Sun L., Xue R., Xu J., and Liu Z. Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion. J Nutr Biochem 17 (2006) 234-241
35. Bas O., Songur A., Sahin O., Mollaoglu H., Ozen O.A., Yaman M., et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem Int 50 (2007) 548-554
36. Akbar M., Calderon F., Wen Z., and Kim H.Y. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 102 (2005) 10858-10863
37. Chen W., Esselman W.J., Jump D.B., and Busik J.V. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 46 (2005) 4342-4347
38. Florent S., Malaplate-Armand C., Youssef I., Kriem B., Koziel V., Escanyé M.C., et al. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-β oligomers. J Neurochem 96 (2006) 385-395
39. German O.L., Insua M.F., Gentili C., Rotstein N.P., and Politi L.E. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. J Neurochem 98 (2006) 1507-1520
40. Kao T.K., Ou Y.C., Kuo J.S., Chen W.Y., Liao S.L., Wu C.W., et al. Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats. Neurochem Int 48 (2006) 166-176
41. Chen C.J., and Liao S.L. Oxidative stress involve in astrocytic alterations induced by manganese. Exp Neurol 175 (2002) 216-225
42. Chen C.J., Chen J.H., Chen S.Y., Liao S.L., and Raung S.L. Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection. J Virol 78 (2004) 12107-12119
43. Kondo T., Reaume A.G., Huang T.T., Carlson E., Murakami K., Chen S.F., et al. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci 17 (1997) 4180-4189
44. Eldadah B.A., and Faden A.I. Caspase pathways, neuronal apoptosis, and CNS injury. J Neurotrauma 17 (2000) 811-829
45. Nicholson D.W., and Thornberry N.A. Caspases: killer proteases. Trends Biochem Sci 22 (1997) 299-306
46. Calder P.C., and Grimble R.F. Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 56 (2002) S14-S19
47. Calder P.C. n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38 (2003) 343-352
48. Kim G.W., Kondo T., Noshita N., and Chan P.H. Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke 33 (2002) 809-815
49. Black K.L., Hoff J.T., Radin N.S., and Deshmukh G.D. Eicosapentaenoic acid: effect on brain prostaglandins, cerebral blood flow and edema in ischemic gerbils. Stroke 15 (1984) 65-69
50. Desire L., Courtois Y., and Jeanny J.C. Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal bcl-x(L) and bcl-2 expression through a fibroblast growth factor receptor 1- and ERK-dependent pathway. J Neurochem 75 (2000) 151-163
51. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., and Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 80 (1995) 285-291
52. Adachi S., Cross A.R., Babior B.M., and Gottlieb R.A. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J Biol Chem 272 (1997) 21878-21882
53. Bazan N.G. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10 (2007) 136-141